4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
15.39
-0.44 (-2.78%)
Aug 24, 2026, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $850.21 million as of August 25, 2026. Its market cap has increased by 156.77% in one year.
Market Cap
850.21M
Enterprise Value
458.80M
1-Year Change
156.77%
Ranking
Category
Stock Price
$15.39
ChartMarket Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $850.21M, an increase of 46.49%. That is a compound annual growth rate of 6.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 850.21M | 98.41% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Faeth Therapeutics | 896.92M |
| Attovia Therapeutics | 887.26M |
| Theravance Biopharma | 883.14M |
| SpyGlass Pharma | 878.34M |
| Rigel Pharmaceuticals | 842.65M |
| DBV Technologies | 841.82M |
| Aura Biosciences | 819.27M |
| Achieve Life Sciences | 817.05M |